People: Novogen Ltd (NVGN.O)
NVGN.O on Consolidated Issue listed on NASDAQ Capital Market
4.08USD
19 Jun 2013
4.08USD
19 Jun 2013
Price Change (% chg)
$-0.02 (-0.49%)
$-0.02 (-0.49%)
Prev Close
$4.10
$4.10
Open
$4.10
$4.10
Day's High
$4.20
$4.20
Day's Low
$4.08
$4.08
Volume
8,500
8,500
Avg. Vol
74,998
74,998
52-wk High
$10.49
$10.49
52-wk Low
$1.47
$1.47
Kearney, Craig
Brief Biography
Mr. Craig D. Kearney is General Manager - Consumer Business of Novogen Ltd since December 2001. He has a Bachelor of Management Studies from Waikato University in New Zealand and has subsequently completed managerial development programs at London School of Business and Duke University in Durham, North Carolina. He has worked 19 years in the Over The Counter (OTC) consumer pharmaceutical category, including 10 years for Wellcome New Zealand and Wellcome Australia, and 6 years for Parke Davis/Warner Lambert Australia. Prior to joining Novogen Limited, Mr. Kearney worked for Pfizer Australia. He held senior sales, marketing and business management roles for all three companies.
Basic Compensation
| Total Annual Compensation, AUD | Long-Term Incentive Plans, AUD | All Other, AUD | Fiscal Year Total, AUD |
|---|---|---|---|
| 60,864 | -- | 420,113 | 480,977 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
John O'Connor |
-- |
Graham Kelly |
402,148 |
Mark Hinze |
325,903 |
Andrew Heaton |
-- |
Daniel Gold |
814,617 |
David Brown |
-- |
As Of 29 Jun 2012

